0.601

4.60% -0.029

After Hours: .601

Forte Biosciences Inc (FBRX)

Overview News Price History Option Chain Financials Discussions Forecast

Forte Biosciences Inc stock is currently priced at $0.601, with a 24-hour trading volume of 32,498. It has seen a -4.60% decreased in the last 24 hours and a -18.78% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $0.6695 pivot point. If it approaches the $0.5905 support level, significant changes may occur.

Previous Close:

$0.63

Open:

$0.644

24h Volume:

32,498

Market Cap:

$21.90M

Revenue:

Net Income/Loss:

$-31.48M

P/E Ratio:

-0.5181

EPS:

-1.16

Net Cash Flow:

$-28.71M

1W Performance:

-19.33%

1M Performance:

-18.78%

6M Performance:

+33.85%

1Y Performance:

-41.65%

1D Range:

$0.60

$0.675

52W Range:

$0.38

$1.07

Forte Biosciences Inc Stock (FBRX) Company Profile

Name

Forte Biosciences Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

310 618 6994

Address

3060 Pegasus Park Drive, Building 6, Dallas, CA

Employee

Twitter

Next Earnings Date

2024-05-13

Latest SEC Filings

FBRX's Discussions on Twitter

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-20-21	Upgrade	Chardan Capital Markets	Sell → Buy
Sep-03-21	Downgrade	B. Riley Securities	Buy → Neutral
Sep-03-21	Downgrade	Chardan Capital Markets	Buy → Sell
Sep-03-21	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-03-21	Downgrade	Truist	Buy → Hold
May-14-21	Initiated	B. Riley Securities	Buy
Mar-26-21	Initiated	Citigroup	Buy
Aug-28-20	Upgrade	Chardan Capital Markets	Neutral → Buy
Aug-25-20	Initiated	Truist	Buy

View All

Forte Biosciences Inc Stock (FBRX) Latest News

FY2024 EPS Estimates for The Interpublic Group of Companies, Inc. Lifted by Analyst (NYSE:IPG) - Defense World

Defense World

Marvell Technology, Inc. (NASDAQ:MRVL) CEO Sells $2075400.00 in Stock - Defense World

Defense World

WASTE CONNECTIONS ANNUAL SHAREHOLDERS MEETING RESULTS - Yahoo Canada Finance

Yahoo Canada Finance

Compass Therapeutics, Inc. (NASDAQ:CMPX) Forecasted to Post Q2 2024 Earnings of ($0.11) Per Share - Defense World

Defense World

Q2 2024 EPS Estimates for Centessa Pharmaceuticals plc Increased by Leerink Partnrs (NASDAQ:CNTA) - Defense World

Defense World

Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Recommendation of “Buy” by Brokerages - Defense World

Defense World

Forte Biosciences Inc Stock (FBRX) Financials Data

Forte Biosciences Inc (FBRX) Net Income 2024

FBRX net income (TTM) was -$31.48 million for the quarter ending December 31, 2023, a -126.79% decrease year-over-year.

Forte Biosciences Inc (FBRX) Cash Flow 2024

FBRX recorded a free cash flow (TTM) of -$28.71 million for the quarter ending December 31, 2023, a -250.71% decrease year-over-year.

Forte Biosciences Inc (FBRX) Earnings per Share 2024

FBRX earnings per share (TTM) was -$1.04 for the quarter ending December 31, 2023, a -30.00% decline year-over-year.

Forte Biosciences Inc Stock (FBRX) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Wagner Paul A.	SEE REMARKS	Apr 01 '24	Option Exercise	0.00	31,250	0	1,881,627
Riley Antony A	Chief Financial Officer	Jan 01 '24	Option Exercise	0.00	9,375	0	192,285
Chen Hubert C	See remarks	Jan 01 '24	Option Exercise	0.00	7,500	0	96,478
Wagner Paul A.	See Remarks	Jan 01 '24	Option Exercise	0.00	31,250	0	1,854,486
Wagner Paul A.	See Remarks	Dec 18 '23	Buy	0.75	10,000	7,525	1,823,236
Wagner Paul A.	See Remarks	Dec 14 '23	Buy	0.72	10,000	7,200	1,813,236
Wagner Paul A.	See Remarks	Dec 13 '23	Buy	0.70	10,520	7,351	1,803,236
Wagner Paul A.	See Remarks	Dec 12 '23	Buy	0.65	4,776	3,088	1,792,716
Wagner Paul A.	See Remarks	Dec 11 '23	Buy	0.65	25,000	16,188	1,787,940
Wagner Paul A.	See Remarks	Dec 08 '23	Buy	0.62	15,000	9,300	1,762,940

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.